{"version":"1","article":{"id":"sidra-neuroblastoma-therapies-september-2026","slug":"sidra-neuroblastoma-therapies-september-2026","language":"en","url":"https://haberpaper.com/en/news/sidra-neuroblastoma-therapies-september-2026","api_url":"https://haberpaper.com/api/v1/articles/sidra-neuroblastoma-therapies-september-2026?lang=en","title":"Sidra introduces two therapies for childhood neuroblastoma","summary":"Sidra Medicine says it has administered naxitamab for the first time in the Gulf Cooperation Council region and dinutuximab beta for the first time in Qatar to treat high-risk neuroblastoma. Both are anti-GD2 monoclonal antibody therapies.","category":"business","region":"world","topics":["health"],"published_at":"2026-10-10T23:57:14+03:00","modified_at":"2026-10-10T23:57:14+03:00","publication_basis":"publication-record","event_period":"2026-09-30","event_period_basis":"event-or-reference-period","sources":[{"name":"Sidra Medicine","url":"https://www.sidra.org/media/news/2026/sidra-medicine-introduces-two-new-specialized-therapies-for-children-with-high-risk-neuroblastoma/","checkedAt":"2026-10-10","publishedAt":"2026-09-30"}],"translations":[{"language":"tr","url":"https://haberpaper.com/tr/news/sidra-neuroblastoma-therapies-september-2026","api_url":"https://haberpaper.com/api/v1/articles/sidra-neuroblastoma-therapies-september-2026?lang=tr"},{"language":"en","url":"https://haberpaper.com/en/news/sidra-neuroblastoma-therapies-september-2026","api_url":"https://haberpaper.com/api/v1/articles/sidra-neuroblastoma-therapies-september-2026?lang=en"},{"language":"ar","url":"https://haberpaper.com/ar/news/sidra-neuroblastoma-therapies-september-2026","api_url":"https://haberpaper.com/api/v1/articles/sidra-neuroblastoma-therapies-september-2026?lang=ar"},{"language":"fr","url":"https://haberpaper.com/fr/news/sidra-neuroblastoma-therapies-september-2026","api_url":"https://haberpaper.com/api/v1/articles/sidra-neuroblastoma-therapies-september-2026?lang=fr"},{"language":"es","url":"https://haberpaper.com/es/news/sidra-neuroblastoma-therapies-september-2026","api_url":"https://haberpaper.com/api/v1/articles/sidra-neuroblastoma-therapies-september-2026?lang=es"}],"data_types":[],"data":null,"data_compilations":[],"data_downloads":[],"content":{"paragraphs":["Sidra Medicine announced on 30 September that it had introduced two specialised therapies for children with high-risk neuroblastoma: naxitamab (Danyelza), for the first time in the GCC, and dinutuximab beta (Qarziba), for the first time in Qatar. The hospital said both medicines are anti-GD2 monoclonal antibody therapies.","The treatments were administered to two patients after stem-cell transplantation. Sidra said the work involved coordination between its paediatric haematology and oncology and haematopoietic stem-cell transplant teams, adding to the specialised options available at the hospital for high-risk neuroblastoma."],"key_points":[],"sections":[]},"text":"Sidra Medicine says it has administered naxitamab for the first time in the Gulf Cooperation Council region and dinutuximab beta for the first time in Qatar to treat high-risk neuroblastoma. Both are anti-GD2 monoclonal antibody therapies.\n\nSidra Medicine announced on 30 September that it had introduced two specialised therapies for children with high-risk neuroblastoma: naxitamab (Danyelza), for the first time in the GCC, and dinutuximab beta (Qarziba), for the first time in Qatar. The hospital said both medicines are anti-GD2 monoclonal antibody therapies.\n\nThe treatments were administered to two patients after stem-cell transplantation. Sidra said the work involved coordination between its paediatric haematology and oncology and haematopoietic stem-cell transplant teams, adding to the specialised options available at the hospital for high-risk neuroblastoma.","corrections":[],"editorial_illustration":{"kind":"symbolic-editorial-illustration","documentary":false,"scope":"section","asset_id":"business","url":"https://haberpaper.com/assets/illustrations/business-1536.webp","width":1536,"height":1024,"alt":"Symbolic industrial workshop with machinery, a warehouse and a crane.","language":"en"},"section_illustration":{"kind":"symbolic-editorial-illustration","documentary":false,"scope":"section","asset_id":"business","url":"https://haberpaper.com/assets/illustrations/business-1536.webp","width":1536,"height":1024,"alt":"Symbolic industrial workshop with machinery, a warehouse and a crane.","language":"en"}}}